Mary Kay Fenton
Overview
Mary Kay Fenton received an average of $2M in total compensation, including $423K in salary, at Tourmaline Bio between 2022 and 2023. Mary Fenton also received an average of $828K at Achillion Pharmaceuticals from 2006 to 2018.
- 2023
- 2022
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
Tourmaline BioFormer Interim Chief Executive Officer and President and Chief Financial Officer
Tourmaline BioFormer Interim Chief Executive Officer and President and Chief Financial Officer
Achillion PharmaceuticalsFormer Executive Vice President, Chief Financial Officer and Treasurer
Achillion PharmaceuticalsFormer Executive Vice President, Chief Financial Officer and Treasurer
Achillion PharmaceuticalsExecutive Vice President and Chief Financial Officer
Achillion PharmaceuticalsExecutive Vice President and Chief Financial Officer
Achillion PharmaceuticalsExecutive Vice President and Chief Financial Officer
Achillion PharmaceuticalsExecutive Vice President and Chief Financial Officer
Achillion PharmaceuticalsExecutive Vice President and Chief Financial Officer
Achillion PharmaceuticalsExecutive Vice President and Chief Financial Officer
Source: SEC filings on April 19, 2024, April 15, 2019, April 17, 2017, April 15, 2016, April 17, 2015, April 18, 2014, April 12, 2013, April 16, 2012, April 19, 2011, April 24, 2008, and April 30, 2007.
Related executives
We found 18 more executives who work or worked at Tourmaline Bio and Achillion Pharmaceuticals.
Scott Requadt
Tourmaline Bio
Chief Executive Officer
Sandeep Kulkarni
Tourmaline Bio
Chief Executive Officer
Michael Zdanowski
Tourmaline Bio
Chief Technology Officer
Nancy Krieger
Tourmaline Bio
Chief Medical Officer
Yung Chyung
Tourmaline Bio
Chief Medical Officer
Kevin Johnson
Tourmaline Bio
Chief Regulatory Officer
Suzanne Ildstad
Tourmaline Bio
Chief Scientific Officer
Joseph Truitt
Achillion Pharmaceuticals